Skip to main content

Table 5 Changes in Clinical and PKG measures following treatment for bradykinesia or dyskinesia

From: A method for measuring time spent in bradykinesia and dyskinesia in people with Parkinson’s disease using an ambulatory monitor

a PwP treated for bradykinesia bradykinesia score ≥ 23 N = 57
  Mean (Std) Δ% ES p value
 Hohn &Yahr   2.4 (1) n/a n/a n/a
 Years of PD   5.7 (3.8) n/a n/a  
 PDQ39 Before 29.8 (19.4)    
After 25.6 (19.1) 14.1% 0.22 0.26
 UPDRS III Before 38 (10.2)    
After 32.7 (10.9) 13.9% 0.49 0.008
 UPDRS Total Before 65.8 (18.4)    
After 55.7 (20.5) 15.4% 0.49 0.003
 Median BKS Before 29.4 (4.2)    
After 27 (4.3) 8.2% 0.59 0.002
 PTB Before 63 (22)    
After 50 (24) 20.6% 0.56 0.004
b PwP treated for dyskinesia PTD ≥ 20% N = 27
  Mean (Std) Δ% ES p value
 Hohn &Yahr   2.4 (0.7) n/a n/a n/a
 Years of PD   9.4 (5.8) n/a n/a n/a
 UPDRS IV Before 7.7 (4)    
  After 4.3 (4.3) 44.2% 0.79 0.0009
 UPDRS Total Before 58 (18)    
  After 45 (23) 22.4% 0.57 0.010
 PTD Before 42 (20)    
  After 23 (16) 45.2% 1.19 0.0007
 Median DKS Before 14 (13)    
  After 6.2 (4.3) 54.9% 1.81 0.0006